{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:11Z","timestamp":1790279951326,"version":"4.1.0"},"reference-count":227,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10529-022-03232-3","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T06:28:30Z","timestamp":1643956110000},"page":"203-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches"],"prefix":"10.1007","volume":"44","author":[{"given":"Murugan","family":"Prasathkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Becky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Anisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenthamara","family":"Dhrisya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-4696","authenticated-orcid":false,"given":"Subramaniam","family":"Sadhasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"3232_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bioorg.2019.02.009","volume":"86","author":"G Abbas","year":"2019","unstructured":"Abbas G, Al Harrasi A, Hussain H, Hamaed A, Supuran CT (2019) The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, \u03b1-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2). Bioorg Chem 86:305\u2013315. https:\/\/doi.org\/10.1016\/j.bioorg.2019.02.009","journal-title":"Bioorg Chem"},{"key":"3232_CR2","doi-asserted-by":"publisher","first-page":"107810","DOI":"10.1016\/j.diabres.2019.107810","volume":"156","author":"H Absil","year":"2019","unstructured":"Absil H, Baudet L, Robert A, Lysy PA (2019) Benefits of physical activity in children and adolescents with type 1 diabetes: a systematic review. Diabetes Res Clin Pract 156:107810. https:\/\/doi.org\/10.1016\/j.diabres.2019.107810","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR220","doi-asserted-by":"publisher","unstructured":"Adeghate J, Nurulain S, Tekes K, Feh\u00e9r E, Kal\u00e1sz H, Adeghate E (2017) Novel biological therapies for the treatment of diabetic foot ulcers. Expert Opin Biol Ther 17:979\u2013987. https:\/\/doi.org\/10.1080\/14712598.2017.1333596","DOI":"10.1080\/14712598.2017.1333596"},{"key":"3232_CR3","doi-asserted-by":"publisher","first-page":"S712","DOI":"10.1016\/S2222-1808(14)60712-X","volume":"4","author":"M Ademe","year":"2014","unstructured":"Ademe M, Mekonnen Z (2014) Repeated reuse of insulin injection syringes and incidence of bacterial contamination among diabetic patients in Jimma University Specialized Hospital, Jimma, Ethiopia. Asian Pacific J Trop Dis 4:S712\u2013S716. https:\/\/doi.org\/10.1016\/S2222-1808(14)60712-X","journal-title":"Asian Pacific J Trop Dis"},{"key":"3232_CR4","doi-asserted-by":"publisher","first-page":"117350","DOI":"10.1016\/j.lfs.2020.117350","volume":"245","author":"I Ahmad","year":"2020","unstructured":"Ahmad I, Hoda M (2020) Attenuation of diabetic retinopathy and neuropathy by resveratrol: review on its molecular mechanisms of action. Life Sci 245:117350. https:\/\/doi.org\/10.1016\/j.lfs.2020.117350","journal-title":"Life Sci"},{"key":"3232_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/biom9090430","volume":"9","author":"RK AL-Ishaq","year":"2019","unstructured":"AL-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, B\u00fcsselberg D (2019) Flavonoids and their anti-diabetic effects: cellular mechanisms and effects to improve blood sugar levels. Biomolecules 9:430. https:\/\/doi.org\/10.3390\/biom9090430","journal-title":"Biomolecules"},{"key":"3232_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.abb.2017.05.010","volume":"623","author":"KM Allen","year":"2017","unstructured":"Allen KM, Coughlan KA, Mahmood FN, Valentine RJ, Ruderman NB, Saha AK (2017) The effects of troglitazone on AMPK in HepG2 cells. Arch Biochem Biophys 623:49\u201357. https:\/\/doi.org\/10.1016\/j.abb.2017.05.010","journal-title":"Arch Biochem Biophys"},{"key":"3232_CR7","doi-asserted-by":"publisher","first-page":"s106","DOI":"10.2337\/diacare.27.2007.S106","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association (2004) Insulin administration. Diabetes Care 27:s106\u2013s107. https:\/\/doi.org\/10.2337\/diacare.27.2007.S106","journal-title":"Diabetes Care"},{"key":"3232_CR8","doi-asserted-by":"publisher","first-page":"e23999","DOI":"10.1371\/journal.pone.0023999","volume":"6","author":"AS Andreasen","year":"2011","unstructured":"Andreasen AS, Kelly M, Berg RMG, M\u00f8ller K, Pedersen BK (2011) Type 2 diabetes is associated with altered NF-\u03baB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS. PLoS ONE 6:e23999. https:\/\/doi.org\/10.1371\/journal.pone.0023999","journal-title":"PLoS ONE"},{"key":"3232_CR9","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0016","author":"H Anhalt","year":"2010","unstructured":"Anhalt H, Bohannon NJ (2010) Insulin patch pumps: their development and future in closed-loop systems. Diabetes Technol Ther. https:\/\/doi.org\/10.1089\/dia.2010.0016","journal-title":"Diabetes Technol Ther"},{"key":"3232_CR10","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9531.127541","author":"M Asif","year":"2014","unstructured":"Asif M (2014) The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. https:\/\/doi.org\/10.4103\/2277-9531.127541","journal-title":"J Educ Health Promot"},{"key":"3232_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imu.2018.04.002","volume":"11","author":"OS Ayanlade","year":"2018","unstructured":"Ayanlade OS, Oyebisi TO, Kolawole BA (2018) Development of an ICT-based framework towards sustainable optimal diabetes management in Nigerian health sector. Inform Med Unlocked 11:36\u201343. https:\/\/doi.org\/10.1016\/j.imu.2018.04.002","journal-title":"Inform Med Unlocked"},{"key":"3232_CR12","doi-asserted-by":"publisher","first-page":"173004","DOI":"10.1016\/j.ejphar.2020.173004","volume":"873","author":"S Babu","year":"2020","unstructured":"Babu S, Krishnan M, Rajagopal P, Periyasamy V, Veeraraghavan V, Govindan R, Jayaraman S (2020) Beta-sitosterol attenuates insulin resistance in adipose tissue via IRS-1\/Akt mediated insulin signaling in high fat diet and sucrose induced type-2 diabetic rats. Eur J Pharmacol 873:173004. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173004","journal-title":"Eur J Pharmacol"},{"key":"3232_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11892-019-1157-y","volume":"19","author":"DP Barlovic","year":"2019","unstructured":"Barlovic DP, Tikkanen-Dolenc H, Groop PH (2019) Physical activity in the prevention of development and progression of kidney disease in type 1 diabetes. Curr Diab Rep 19:41. https:\/\/doi.org\/10.1007\/s11892-019-1157-y","journal-title":"Curr Diab Rep"},{"key":"3232_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1368-5031.2004.00178.x","volume":"58","author":"AH Barnett","year":"2004","unstructured":"Barnett AH (2004) Exubera inhaled insulin: a review. Int J Clin Pract 58:394\u2013401. https:\/\/doi.org\/10.1111\/j.1368-5031.2004.00178.x","journal-title":"Int J Clin Pract"},{"key":"3232_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.aprim.2017.06.012","volume":"50","author":"E Barreira","year":"2018","unstructured":"Barreira E, Novo A, Vaz JA, Pereira AM (2018) Dietary program and physical activity impact on biochemical markers in patients with type 2 diabetes: a systematic review. Aten Primaria 50:590\u2013610. https:\/\/doi.org\/10.1016\/j.aprim.2017.06.012","journal-title":"Aten Primaria"},{"key":"3232_CR16","first-page":"38","volume":"59","author":"MP Baruah","year":"2011","unstructured":"Baruah MP (2011) Insulin pens: the modern delivery devices. J Assoc Phys India 59:38\u201340","journal-title":"J Assoc Phys India"},{"key":"3232_CR17","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1002\/dmrr.205","volume":"18","author":"BW Bode","year":"2002","unstructured":"Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC (2002) Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 18:S14\u2013S20. https:\/\/doi.org\/10.1002\/dmrr.205","journal-title":"Diabetes Metab Res Rev"},{"key":"3232_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnesp.2018.09.003","volume":"28","author":"LP Bricarello","year":"2018","unstructured":"Bricarello LP, Poltronieri F, Fernandes R, Retondario A, de Moraes Trindade EBS, de Vasconcelos FDAG (2018) Effects of the dietary approach to stop hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: a systematic review. Clin Nutr ESPEN 28:1\u201311. https:\/\/doi.org\/10.1016\/j.clnesp.2018.09.003","journal-title":"Clin Nutr ESPEN"},{"key":"3232_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1553-7250(16)30109-X","volume":"42","author":"KE Brown","year":"2016","unstructured":"Brown KE, Hertig JB (2016) Determining current insulin pen use practices and errors in the inpatient setting. Jt Comm J Qual Patient Saf 42:568. https:\/\/doi.org\/10.1016\/S1553-7250(16)30109-X","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"3232_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/ki.2009.4","volume":"75","author":"SM Brunelli","year":"2009","unstructured":"Brunelli SM, Thadhani R, Ikizler TA, Feldman HI (2009) Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes. Kidney Int 75:961\u2013968. https:\/\/doi.org\/10.1038\/ki.2009.4","journal-title":"Kidney Int"},{"key":"3232_CR21","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.pmedr.2019.100877","volume":"14","author":"AK Buelo","year":"2019","unstructured":"Buelo AK, Kirk A, Lindsay RS, Jepson RG (2019) Exploring the effectiveness of physical activity interventions in women with previous gestational diabetes: a systematic review of quantitative and qualitative studies. Prev Med Rep 14:100877. https:\/\/doi.org\/10.1016\/j.pmedr.2019.100877","journal-title":"Prev Med Rep"},{"key":"3232_CR22","doi-asserted-by":"publisher","first-page":"104013","DOI":"10.1016\/j.archger.2020.104013","volume":"88","author":"EA Bulut","year":"2020","unstructured":"Bulut EA, Alak ZYS, Dokuzlar O, Kocyigit SE, Soysal P, Smith L, Isik AT (2020) Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study. Arch Gerontol Geriat 88:104013","journal-title":"Arch Gerontol Geriat"},{"key":"3232_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jnim.2018.07.003","volume":"14","author":"SYP Candidate","year":"2018","unstructured":"Candidate SYP, Candidate JSP, Nissa Mazzola Pharm DCDE (2018) Nutritional supplements for the prevention of diabetes mellitus and its complications. J Nutr Intermed Metab 14:16\u201321. https:\/\/doi.org\/10.1016\/j.jnim.2018.07.003","journal-title":"J Nutr Intermed Metab"},{"key":"3232_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.diabet.2019.101117","volume":"46","author":"MS Capehorn","year":"2020","unstructured":"Capehorn MS, Catarig AM, Furberg JK, Janez A, Price HC, Tadayon S, Marre M (2020) Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1\u20133 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10). Diabetes Metab J 46:100\u2013109. https:\/\/doi.org\/10.1016\/j.diabet.2019.101117","journal-title":"Diabetes Metab J"},{"key":"3232_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijnss.2018.12.002","volume":"6","author":"R Carpenter","year":"2019","unstructured":"Carpenter R, DiChiacchio T, Barker K (2019) Interventions for self-management of type 2 diabetes: an integrative review. Int J Nurs Sci 6:70\u201391. https:\/\/doi.org\/10.1016\/j.ijnss.2018.12.002","journal-title":"Int J Nurs Sci"},{"key":"3232_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","volume":"27","author":"L Catrysse","year":"2017","unstructured":"Catrysse L, van Loo G (2017) Inflammation and the metabolic syndrome: the tissue-specific functions of NF-\u03baB. Trends Cell Biol 27:417\u2013429. https:\/\/doi.org\/10.1016\/j.tcb.2017.01.006","journal-title":"Trends Cell Biol"},{"key":"3232_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0828-y","volume":"18","author":"CMA Cefalo","year":"2019","unstructured":"Cefalo CMA, Cinti F, Moffa S, Impronta F, Sorice GP, Mezza T, Giaccari A (2019) Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives. Cardiovasc Diabetol 18:1\u201314. https:\/\/doi.org\/10.1186\/s12933-019-0828-y","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"3232_CR28","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2337\/dc14-1395","volume":"37","author":"WT Cefalu","year":"2014","unstructured":"Cefalu WT, Buse JB, Del Prato S, Home PD, LeRoith D, Nauck MA, Riddle MC (2014) Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors\u2019 expert forum. Diabetes Care 37(9):2647\u20132659. https:\/\/doi.org\/10.2337\/dc14-1395","journal-title":"Diabetes Care"},{"key":"3232_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.7326\/M16-2937","volume":"166","author":"JJ Chamberlain","year":"2017","unstructured":"Chamberlain JJ, Herman WH, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Kalyani RR (2017) Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med 166:572\u2013578. https:\/\/doi.org\/10.7326\/M16-2937","journal-title":"Ann Intern Med"},{"key":"3232_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2017.00006","volume":"8","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, Sasapu A (2017) Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol 8:6. https:\/\/doi.org\/10.3389\/fendo.2017.00006","journal-title":"Front Endocrinol"},{"key":"3232_CR31","doi-asserted-by":"publisher","first-page":"111072","DOI":"10.1016\/j.fct.2019.111072","volume":"136","author":"L Chen","year":"2020","unstructured":"Chen L, Lin X, Fan X, Qian Y, Lv Q, Teng H (2020) Sonchus oleraceus Linn extract enhanced glucose homeostasis through the AMPK\/Akt\/GSK-3\u03b2 signaling pathway in diabetic liver and HepG2 cell culture. Food Chem Toxicol 136:111072. https:\/\/doi.org\/10.1016\/j.fct.2019.111072","journal-title":"Food Chem Toxicol"},{"key":"3232_CR32","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1128\/MCB.01792-08","volume":"29","author":"WS Chen","year":"2009","unstructured":"Chen WS, Peng XD, Wang Y, Xu PZ, Chen ML, Luo Y, Philipson LH (2009) Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol Cell Biol 29:3151\u20133162. https:\/\/doi.org\/10.1128\/MCB.01792-08","journal-title":"Mol Cell Biol"},{"key":"3232_CR33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2009.06.046","volume":"138","author":"SH Chiang","year":"2009","unstructured":"Chiang SH, Bazuine M, Lumeng CN, Geletka LM, Mowers J, White NM, Delproposto JB (2009) The protein kinase IKK\u025b regulates energy balance in obese mice. Cell 138:961\u2013975. https:\/\/doi.org\/10.1016\/j.cell.2009.06.046","journal-title":"Cell"},{"key":"3232_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12325-019-0872-8","volume":"2","author":"SR Chowdhury","year":"2019","unstructured":"Chowdhury SR, Alam SSAMF (2019) Medical nutritional therapy in type 2 diabetes mellitus. J Armed Forces Med Coll 2:26\u201332. https:\/\/doi.org\/10.1007\/s12325-019-0872-8","journal-title":"J Armed Forces Med Coll"},{"key":"3232_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","volume":"3","author":"B Cool","year":"2006","unstructured":"Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Zhao G (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3:403\u2013416. https:\/\/doi.org\/10.1016\/j.cmet.2006.05.005","journal-title":"Cell Metab"},{"key":"3232_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/nutrit\/nuw011","volume":"74","author":"RB Costello","year":"2016","unstructured":"Costello RB, Dwyer JT, Bailey RL (2016) Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness. Nutr Rev 74:455\u2013468. https:\/\/doi.org\/10.1093\/nutrit\/nuw011","journal-title":"Nutr Rev"},{"key":"3232_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/DMSO.S43731","volume":"7","author":"KA Coughlan","year":"2014","unstructured":"Coughlan KA, Valentine RJ, Ruderman NB, Saha AK (2014) AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes 7:241. https:\/\/doi.org\/10.2147\/DMSO.S43731","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3232_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.aohep.2019.10.005","volume":"19","author":"V Cunha","year":"2020","unstructured":"Cunha V, Cotrim HP, Rocha R, Carvalho K, Lins-Kusterer L (2020) Metformin in the prevention of hepatocellular carcinoma in diabetic patients: a systematic review. Ann Hepatol 19:232\u2013237. https:\/\/doi.org\/10.1016\/j.aohep.2019.10.005","journal-title":"Ann Hepatol"},{"key":"3232_CR39","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat Med 23:804\u2013814. https:\/\/doi.org\/10.1038\/nm.4350","journal-title":"Nat Med"},{"key":"3232_CR40","doi-asserted-by":"publisher","unstructured":"Dalsgaard NB, Gasbjerg LS, Hansen LS, Hansen NL, Stensen S, Hartmann B, Knop FK (2019) 1145-P: Acarbose-Induced Glucagon-Like Peptide-1 Secretion Contributes to the Glucose-Lowering Effect of Acarbose. https:\/\/doi.org\/10.2337\/db19-1145-P","DOI":"10.2337\/db19-1145-P"},{"key":"3232_CR41","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jada.2007.05.004","volume":"107","author":"A Daly","year":"2007","unstructured":"Daly A (2007) Use of insulin and weight gain: optimizing diabetes nutrition therapy. J Am Diet Assoc 107:1386\u20131393. https:\/\/doi.org\/10.1016\/j.jada.2007.05.004","journal-title":"J Am Diet Assoc"},{"key":"3232_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/msj.20118","volume":"76","author":"N Davis","year":"2009","unstructured":"Davis N, Forbes B, Wylie-Rosett J (2009) Nutritional strategies in type 2 diabetes mellitus. Mount Sinai J Med 76:257\u2013268. https:\/\/doi.org\/10.1002\/msj.20118","journal-title":"Mount Sinai J Med"},{"key":"3232_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jdiacomp.2007.05.001","volume":"22","author":"SN Davis","year":"2008","unstructured":"Davis SN (2008) The role of inhaled insulin in the treatment of type 2 diabetes. J Diabetes Complicat 22:420\u2013429. https:\/\/doi.org\/10.1016\/j.jdiacomp.2007.05.001","journal-title":"J Diabetes Complicat"},{"key":"3232_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107553","author":"DR de Souza","year":"2020","unstructured":"de Souza DR, da Silva Pieri BL, Comim VH, de Oliveira MS, Luciano TF, Rodrigues MS, De Souza CT (2020) Fish oil reduces subclinical inflammation, insulin resistance, and atherogenic factors in overweight\/obese type 2 diabetes mellitus patients: a pre-post pilot study. J Diabetes Complicat. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107553","journal-title":"J Diabetes Complicat"},{"key":"3232_CR45","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/dom.12550","volume":"17","author":"HM De Wit","year":"2015","unstructured":"De Wit HM, Engwerda EEC, Tack CJ, De Galan BE (2015) Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes. Diabetes Obes Metab 17:1093\u20131099. https:\/\/doi.org\/10.1111\/dom.12550","journal-title":"Diabetes Obes Metab"},{"key":"3232_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jobcr.2020.02.003","volume":"10","author":"M Denewar","year":"2020","unstructured":"Denewar M, Amin LE (2020) Role of bone marrow-derived mesenchymal stem cells on the parotid glands of streptozotocin induced diabetes rats. J Oral Biol Craniofac Res 10:33\u201337. https:\/\/doi.org\/10.1016\/j.jobcr.2020.02.003","journal-title":"J Oral Biol Craniofac Res"},{"key":"3232_CR47","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/dia.2011.0204","volume":"14","author":"G Derosa","year":"2012","unstructured":"Derosa G, Maffioli P (2012) Dipeptidyl peptidase-4 inhibitors: 3 years of experience. Diabetes Technol Ther 14:350\u2013364. https:\/\/doi.org\/10.1089\/dia.2011.0204","journal-title":"Diabetes Technol Ther"},{"key":"3232_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jdiacomp.2013.04.007","volume":"27","author":"CV Desouza","year":"2013","unstructured":"Desouza CV (2013) Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes? J Diabetes Complicat 27:519\u2013525. https:\/\/doi.org\/10.1016\/j.jdiacomp.2013.04.007","journal-title":"J Diabetes Complicat"},{"key":"3232_CR49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jopr.2013.07.027","volume":"7","author":"SM Dhole","year":"2013","unstructured":"Dhole SM, Khedekar PB, Amnerkar ND (2013) Validated high performance liquid chromatography method for determination of miglitol in tablet dosage form. J Pharm Res 7:595\u2013599. https:\/\/doi.org\/10.1016\/j.jopr.2013.07.027","journal-title":"J Pharm Res"},{"key":"3232_CR50","doi-asserted-by":"publisher","first-page":"e40074","DOI":"10.1371\/journal.pone.0040074","volume":"7","author":"G Di Pasquale","year":"2012","unstructured":"Di Pasquale G, Dicembrini I, Raimondi L et al (2012) Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity\/type 2 diabetes. PLoS ONE 7:e40074. https:\/\/doi.org\/10.1371\/journal.pone.0040074","journal-title":"PLoS ONE"},{"key":"3232_CR51","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.celrep.2019.04.050","volume":"27","author":"D Ding","year":"2019","unstructured":"Ding D, Wang M, Wu JX, Kang Y, Chen L (2019) The structural basis for the binding of repaglinide to the pancreatic KATP channel. Cell Rep 27:1848\u20131857. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.050","journal-title":"Cell Rep"},{"key":"3232_CR52","unstructured":"Donner T, Sarkar S (2019) Insulin\u2013pharmacology, therapeutic regimens, and principles of intensive insulin therapy. In: Endotext. MDText.com, Inc., South Dartmouth"},{"key":"3232_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.diabres.2016.09.001","volume":"121","author":"EEC Engwerda","year":"2016","unstructured":"Engwerda EEC, Tack CJ, de Galan BE (2016) A comparison of the pharmacodynamic profiles of jet-injected regular human insulin versus conventionally administered insulin aspart in healthy volunteers. Diabetes Res ClinPract 121:86\u201390. https:\/\/doi.org\/10.1016\/j.diabres.2016.09.001","journal-title":"Diabetes Res ClinPract"},{"key":"3232_CR54","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2337\/dc11-0182","volume":"34","author":"EE Engwerda","year":"2011","unstructured":"Engwerda EE, Abbink EJ, Tack CJ, De Galan BE (2011) Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. Diabetes Care 34:1804\u20131808. https:\/\/doi.org\/10.2337\/dc11-0182","journal-title":"Diabetes Care"},{"key":"3232_CR221","doi-asserted-by":"publisher","unstructured":"Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, Ertas YN, Mirzaei S, Samarghandian S (2022) AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a preclinical and clinical investigation. Biomed Pharmacother 146:112563. https:\/\/doi.org\/10.1016\/j.biopha.2021.112563","DOI":"10.1016\/j.biopha.2021.112563"},{"key":"3232_CR55","doi-asserted-by":"publisher","first-page":"e008222","DOI":"10.1136\/bmjopen-2015-008222","volume":"5","author":"K Esposito","year":"2015","unstructured":"Esposito K, Maiorino MI, Bellastella G, Chiodini P, Panagiotakos D, Giugliano D (2015) A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open 5:e008222. https:\/\/doi.org\/10.1136\/bmjopen-2015-008222","journal-title":"BMJ Open"},{"key":"3232_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.diabres.2010.04.019","volume":"89","author":"K Esposito","year":"2010","unstructured":"Esposito K, MaiorinoMI CA, Giugliano D (2010) Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract 89:97\u2013102. https:\/\/doi.org\/10.1016\/j.diabres.2010.04.019","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR57","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.2337\/dc14-S120","volume":"37","author":"AB Evert","year":"2014","unstructured":"Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Yancy WS (2014) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 37:S120\u2013S143. https:\/\/doi.org\/10.2337\/dc14-S120","journal-title":"Diabetes Care"},{"key":"3232_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1751-486X.12177","volume":"19","author":"HC Fantasia","year":"2015","unstructured":"Fantasia HC (2015) Inhaled insulin\u2014a new delivery for an old drug. Nurs Women\u2019s Health 19:67\u201370. https:\/\/doi.org\/10.1111\/1751-486X.12177","journal-title":"Nurs Women's Health"},{"key":"3232_CR59","doi-asserted-by":"publisher","unstructured":"Farooqui AA, Farooqui T (2018) Effect of mediterranean diet components on type 2 diabetes and metabolic syndrome. In: Role of the mediterranean diet in the brain and neurodegenerative diseases, pp. 209\u2013222. https:\/\/doi.org\/10.1016\/B978-0-12-811959-4.00013-4","DOI":"10.1016\/B978-0-12-811959-4.00013-4"},{"key":"3232_CR60","doi-asserted-by":"publisher","first-page":"107418","DOI":"10.1016\/j.jdiacomp.2019.107418","volume":"33","author":"L Florez","year":"2019","unstructured":"Florez L, Shubina M, Turchin A (2019) Predictors of glycemic control after decline of insulin therapy by patients with type 2 diabetes. J Diabetes Complicat 33:107418. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107418","journal-title":"J Diabetes Complicat"},{"key":"3232_CR61","unstructured":"Food Nutrition and Security Analysis. India (2019) Ministry of Statistics and Programme Implementation &The World Food Programme. http:\/\/www.indiaenvironmentportal.org.in\/files\/file\/Food%20and%20Nutrition%20Security%20Analysis.pdf. Accessed Feb 2020"},{"key":"3232_CR62","doi-asserted-by":"publisher","first-page":"k2234","DOI":"10.1136\/bmj.k2234","volume":"361","author":"NG Forouhi","year":"2018","unstructured":"Forouhi NG, Misra A, Mohan V, Taylor R, Yancy W (2018) Dietary and nutritional approaches for prevention and management of type 2 diabetes. Bmj 361:k2234","journal-title":"Bmj"},{"key":"3232_CR63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.amjms.2016.02.001","volume":"351","author":"MJ Franz","year":"2016","unstructured":"Franz MJ (2016) Diabetes nutrition therapy: effectiveness, macronutrients, eating patterns and weight management. Am J Med Sci 351:374\u2013379. https:\/\/doi.org\/10.1016\/j.amjms.2016.02.001","journal-title":"Am J Med Sci"},{"key":"3232_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1507\/endocrj.EJ18-0466","volume":"66","author":"J Fu","year":"2019","unstructured":"Fu J, Liu J, Xu Y, Yang N, Yang W, Wang G (2019) Comparison of therapeutic effects of acarbose and metformin under different \u03b2-cell function status in Chinese patients with type 2 diabetes. Endocr J 66:443\u2013450. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0466","journal-title":"Endocr J"},{"key":"3232_CR65","unstructured":"Ganesan K, Rana MBM, Sultan S (2020) Oral Hypoglycemic Medications. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"3232_CR66","doi-asserted-by":"publisher","first-page":"104557","DOI":"10.1016\/j.psyneuen.2019.104557","volume":"113","author":"MJ Gangel","year":"2020","unstructured":"Gangel MJ, Dollar J, Brown A, Keane S, Calkins SD, Shanahan L, Wideman L (2020) Childhood social preference and adolescent insulin resistance: accounting for the indirect effects of obesity. Psychoneuroendocrinology 113:104557. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104557","journal-title":"Psychoneuroendocrinology"},{"key":"3232_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13287-018-1084-x","volume":"9","author":"LR Gao","year":"2018","unstructured":"Gao LR, Zhang NK, Zhang Y, Chen Y, Wang L, Zhu Y, Tang HH (2018) Overexpression of apelin in Wharton\u2019jellymesenchymal stem cell reverses insulin resistance and promotes pancreatic \u03b2 cell proliferation in type 2 diabetic rats. Stem Cell Res Ther 9:339. https:\/\/doi.org\/10.1186\/s13287-018-1084-x","journal-title":"Stem Cell Res Ther"},{"key":"3232_CR68","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/archinte.163.15.1781","volume":"163","author":"AJ Garber","year":"2003","unstructured":"Garber AJ (2003) Benefits of combination therapy of insulin and oral hypoglycemic agents. JAMA Intern Med 163:1781\u20131782. https:\/\/doi.org\/10.1001\/archinte.163.15.1781","journal-title":"JAMA Intern Med"},{"key":"3232_CR69","doi-asserted-by":"publisher","unstructured":"Garcia D, Mihaylova MM, Shaw RJ (2020) AMPK: Central Regulator of Glucose and Lipid Metabolism and Target of Type 2 Diabetes Therapeutics.\u00a0In: Irwin M, Harvey J,\u00a0James L,\u00a0David E,\u00a0David,\u00a0Snorri S,\u00a0Allan W (ed)The Liver: Biology and Pathobiology, 6thedn. Wiley, New York 472\u2013484. https:\/\/doi.org\/10.1002\/9781119436812.ch38","DOI":"10.1002\/9781119436812.ch38"},{"key":"3232_CR70","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Fern\u00e1ndez E, Leon-Sanz M (2019) Nutrition and Disease: Type 2 Diabetes Mellitus.43\u201348.","DOI":"10.1016\/B978-0-08-100596-5.21909-4"},{"key":"3232_CR71","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.conctc.2019.100427","volume":"18","author":"NM Gatto","year":"2020","unstructured":"Gatto NM, Bracken MB, Kolitsopoulos F, Duggan WT, Koch GG, Wise RA, Jackson NC (2020) Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME). Contempclin Trials Commun 18:100427. https:\/\/doi.org\/10.1016\/j.conctc.2019.100427","journal-title":"Contempclin Trials Commun"},{"key":"3232_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jfda.2018.06.007","volume":"27","author":"A Gedawy","year":"2019","unstructured":"Gedawy A, Al-Salami H, Dass CR (2019) Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. J Food Drug Anal 27:315\u2013322. https:\/\/doi.org\/10.1016\/j.jfda.2018.06.007","journal-title":"J Food Drug Anal"},{"key":"3232_CR73","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.molmed.2019.07.003","volume":"25","author":"E Gendaszewska-Darmach","year":"2019","unstructured":"Gendaszewska-Darmach E, Drzazga A, Kozio\u0142kiewicz M (2019) Targeting GPCRs activated by fatty acid-derived lipids in type 2 diabetes. Trends Mol Med 25:915\u2013929. https:\/\/doi.org\/10.1016\/j.molmed.2019.07.003","journal-title":"Trends Mol Med"},{"key":"3232_CR74","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.dsx.2016.08.009","volume":"11","author":"AA Ghadge","year":"2017","unstructured":"Ghadge AA, Kuvalekar AA (2017) Controversy of oral hypoglycemic agents in type 2 diabetes mellitus: Novel move towards combination therapies. Diabetes Metab Syndr 11:S5\u2013S13. https:\/\/doi.org\/10.1016\/j.dsx.2016.08.009","journal-title":"Diabetes Metab Syndr"},{"key":"3232_CR75","first-page":"27","volume":"13","author":"BH Ginsberg","year":"2019","unstructured":"Ginsberg BH (2019) Patch pumps for insulin. J Diabetes SciTechnol 13:27\u201333","journal-title":"J Diabetes SciTechnol"},{"key":"3232_CR76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bcdf.2017.07.005","volume":"14","author":"HD Goff","year":"2018","unstructured":"Goff HD, Repin N, Fabek H, El Khoury D, Gidley MJ (2018) Dietary fibre for glycaemia control: towards a mechanistic understanding. Bioact Carbohydr Dietary Fibre 14:39\u201353. https:\/\/doi.org\/10.1016\/j.bcdf.2017.07.005","journal-title":"Bioact Carbohydr Dietary Fibre"},{"key":"3232_CR77","unstructured":"Goyal R, Jialal I (2019) Glucose intolerance. InStatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"3232_CR78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0149-2918(98)80058-1","volume":"20","author":"MR Graff","year":"1998","unstructured":"Graff MR, McClanahan MA (1998) Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. ClinTher 20:486\u2013496. https:\/\/doi.org\/10.1016\/S0149-2918(98)80058-1","journal-title":"ClinTher"},{"key":"3232_CR79","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/2165079916644263","volume":"64","author":"JS Grant","year":"2016","unstructured":"Grant JS, Graven LJ (2016) Progressing from metformin to sulfonylureas or meglitinides. Workplace Health Saf 64:433\u2013439","journal-title":"Workplace Health Saf"},{"key":"3232_CR80","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.2337\/db11-0263","volume":"60","author":"CJ Green","year":"2011","unstructured":"Green CJ, Pedersen M, Pedersen BK, Scheele C (2011) Elevated NF-\u03baB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase. Diabetes 60:2810\u20132819. https:\/\/doi.org\/10.2337\/db11-0263","journal-title":"Diabetes"},{"key":"3232_CR81","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diabres.2016.08.022","volume":"121","author":"H Guo","year":"2016","unstructured":"Guo H, Fang C, Huang Y, Pei Y, Chen L, Hu J (2016) The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 121:184\u2013191. https:\/\/doi.org\/10.1016\/j.diabres.2016.08.022","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR82","doi-asserted-by":"publisher","first-page":"e5482","DOI":"10.1097\/MD.0000000000005482","volume":"96","author":"L Guo","year":"2017","unstructured":"Guo L, Xiao X, Sun X, Qi C (2017) Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients. Medicine 96:e5482","journal-title":"Medicine"},{"key":"3232_CR83","doi-asserted-by":"publisher","first-page":"100183","DOI":"10.1016\/j.obmed.2020.100183","volume":"17","author":"A Gupta","year":"2020","unstructured":"Gupta A, Behl T, Sachdeva M (2020) Key milestones in the diabetes research: a comprehensive update. Obes Med 17:100183. https:\/\/doi.org\/10.1016\/j.obmed.2020.100183","journal-title":"Obes Med"},{"key":"3232_CR84","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ecl.2016.06.010","volume":"45","author":"O Hamdy","year":"2016","unstructured":"Hamdy O, Barakatun-Nisak MY (2016) Nutrition in diabetes. Endocrinol Metab Clin 45:799\u2013817. https:\/\/doi.org\/10.1016\/j.ecl.2016.06.010","journal-title":"Endocrinol Metab Clin"},{"key":"3232_CR85","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.envint.2019.02.074","volume":"127","author":"MRH Hansen","year":"2019","unstructured":"Hansen MRH, J\u00f8rs E, Sandb\u00e6k A, Kolstad HA, Schullehner J, Schl\u00fcnssen V (2019) Exposure to neuroactive non-organochlorine insecticides, and diabetes mellitus and related metabolic disturbances: protocol for a systematic review and meta-analysis. Environ Int 127:664\u2013670. https:\/\/doi.org\/10.1016\/j.envint.2019.02.074","journal-title":"Environ Int"},{"key":"3232_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00423-008-0437-9","volume":"395","author":"JW Haveman","year":"2010","unstructured":"Haveman JW, Logtenberg SJ, Kleefstra N, Groenier KH, Bilo HJ, Blomme AM (2010) Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbeck\u2019s Arch Surg 395:65. https:\/\/doi.org\/10.1007\/s00423-008-0437-9","journal-title":"Langenbeck's Arch Surg"},{"key":"3232_CR87","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diabres.2018.05.007","volume":"149","author":"AK Heath","year":"2019","unstructured":"Heath AK, Williamson EJ, Hodge AM, Ebeling PR, Eyles DW, Kvaskoff D, English DR (2019) Vitamin D status and the risk of type 2 diabetes: the Melbourne Collaborative Cohort Study. Diabetes Res Clin Pract 149:179\u2013187. https:\/\/doi.org\/10.1016\/j.diabres.2018.05.007","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR88","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1080\/14656566.2019.1672660","volume":"20","author":"MS Hedrington","year":"2019","unstructured":"Hedrington MS, Davis SN (2019) Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes. Expert Opin Pharmacother 20:2229\u20132235. https:\/\/doi.org\/10.1080\/14656566.2019.1672660","journal-title":"Expert Opin Pharmacother"},{"key":"3232_CR89","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s13340-017-0341-z","volume":"9","author":"T Hirose","year":"2018","unstructured":"Hirose T, Saitoh C, Oikawa I, Kondo N (2018) Efficacy and safety of nateglinide plus sitagliptin combination therapy in type 2 diabetes patients inadequately controlled by sitagliptinmonotherapy: a phase 3, multicenter, open-label, long-term study. Diabetol Int 9:168\u2013178. https:\/\/doi.org\/10.1007\/s13340-017-0341-z","journal-title":"Diabetol Int"},{"key":"3232_CR90","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jcjq.2019.09.002","volume":"45","author":"S Ho","year":"2019","unstructured":"Ho S, Stamm R, Hibbs M, Yoho M, Regli SH, Lorincz I (2019) Is one-pen, one-patient achievable in the hospital? A quality improvement project to reduce risks of inadvertent insulin pen sharing at a large academic medical Center. Jt Comm J Qual Patient Saf 45:814\u2013821. https:\/\/doi.org\/10.1016\/j.jcjq.2019.09.002","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"3232_CR91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molmet.2019.11.016","volume":"32","author":"JM Hoffmann","year":"2020","unstructured":"Hoffmann JM, Gr\u00fcnberg JR, Hammarstedt A, Kroon T, Greiner TU, Maurer S, Hedjazifar S (2020) BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice. Mol Metab 32:15\u201326. https:\/\/doi.org\/10.1016\/j.molmet.2019.11.016","journal-title":"Mol Metab"},{"key":"3232_CR92","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.ijbiomac.2018.07.091","volume":"118","author":"M Hoque","year":"2018","unstructured":"Hoque M, Ali S, Hoda M (2018) Current status of G-protein coupled receptors as potential targets against type 2 diabetes mellitus. Int J Biol Macromol 118:2237\u20132244. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.07.091","journal-title":"Int J Biol Macromol"},{"key":"3232_CR93","first-page":"73","volume":"24","author":"DS Hsia","year":"2017","unstructured":"Hsia DS, Grove O, Cefalu WT (2017) An update on SGLT2 inhibitors for the treatment of diabetes mellitus. CurrOpinEndocrinol Diabetes Obes 24:73","journal-title":"CurrOpinEndocrinol Diabetes Obes"},{"key":"3232_CR94","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2337\/dc11-0442","volume":"34","author":"FB Hu","year":"2011","unstructured":"Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249\u20131257. https:\/\/doi.org\/10.2337\/dc11-0442","journal-title":"Diabetes Care"},{"key":"3232_CR95","doi-asserted-by":"publisher","first-page":"109767","DOI":"10.1016\/j.biopha.2019.109767","volume":"125","author":"DD Huang","year":"2020","unstructured":"Huang DD, Shi G, Jiang Y, Yao C, Zhu C (2020) A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. BiomedPharmacother 125:109767. https:\/\/doi.org\/10.1016\/j.biopha.2019.109767","journal-title":"BiomedPharmacother"},{"key":"3232_CR96","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40265-019-1061-4","volume":"79","author":"S Hussain","year":"2019","unstructured":"Hussain S, Chowdhury TA (2019) The impact of comorbidities on the pharmacological management of type 2 diabetes mellitus. Drugs 79:231\u2013242. https:\/\/doi.org\/10.1007\/s40265-019-1061-4","journal-title":"Drugs"},{"key":"3232_CR97","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jfda.2018.05.008","volume":"26","author":"Y Iizuka","year":"2018","unstructured":"Iizuka Y, Kim H, Hirako S, Chiba K, Wada M, Matsumoto A (2018) Benefits of combination low-dose pioglitazone plus fish oil on aged type 2 diabetes mice. J Food Drug Anal 26:1265\u20131274. https:\/\/doi.org\/10.1016\/j.jfda.2018.05.008","journal-title":"J Food Drug Anal"},{"key":"3232_CR98","doi-asserted-by":"publisher","first-page":"112786","DOI":"10.1016\/j.physbeh.2019.112786","volume":"215","author":"G Jabardo-Camprub\u00ed","year":"2020","unstructured":"Jabardo-Camprub\u00ed G, Donat-Roca R, Sitj\u00e0-Rabert M, Mil\u00e0-Villarroel R, Bort-Roig J (2020) Drop-out ratio between moderate to high-intensity physical exercise treatment by patients with, or at risk of, type 2 diabetes mellitus: a systematic review and meta-analysis. Physiol Behav 215:112786. https:\/\/doi.org\/10.1016\/j.physbeh.2019.112786","journal-title":"Physiol Behav"},{"key":"3232_CR99","doi-asserted-by":"publisher","unstructured":"Ja\u00e9n ML, Vil\u00e0 L, Elias I, Jimenez V, Rod\u00f3 J, Maggioni L, Ruiz-de Gopegui R, Garcia M, Mu\u00f1oz S (2017) Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: eight-year follow-up in dogs. https:\/\/doi.org\/10.1016\/j.omtm.2017.03.008","DOI":"10.1016\/j.omtm.2017.03.008"},{"key":"3232_CR100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.31080\/ecdmr.2020.04.00060","volume":"4","author":"R Jain","year":"2020","unstructured":"Jain R, Olejas S, Feh AR, Edwards A, Abigo I, Zietek W, Khan Z, Ragoonanan S, Benoy N, Bramble D (2020) Review the evidence of life style management in the prevention of type 2-diabetes and compare them to pharmacological interventions. EC Diabetes Metabol Res 4:161\u2013166. https:\/\/doi.org\/10.31080\/ecdmr.2020.04.00060","journal-title":"EC Diabetes Metabol Res"},{"key":"3232_CR101","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.diabres.2010.01.025","volume":"88","author":"M Janghorbani","year":"2010","unstructured":"Janghorbani M, Amini M (2010) Normalization of glucose intolerance in first-degree relatives of patients with type 2 diabetes. Diabetes Res Clin Pract 88:295\u2013301. https:\/\/doi.org\/10.1016\/j.diabres.2010.01.025","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR102","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.bmcl.2011.12.020","volume":"22","author":"DV Jawale","year":"2012","unstructured":"Jawale DV, Pratap UR, Mane RA (2012) An alternative synthetic route for an antidiabetic drug, rosiglitazone. Bioorg Med Chem Lett 22:924\u2013928. https:\/\/doi.org\/10.1016\/j.bmcl.2011.12.020","journal-title":"Bioorg Med Chem Lett"},{"key":"3232_CR103","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/gt.2011.25","volume":"18","author":"M Jean","year":"2011","unstructured":"Jean M, Alameh M, Buschmann MD, Merzouki A (2011) Effective and safe gene-based delivery of GLP-1 using chitosan\/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes. Gene Ther 18:807\u201316. https:\/\/doi.org\/10.1038\/gt.2011.25","journal-title":"Gene Ther"},{"key":"3232_CR104","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/S0140-6736(98)12459-5","volume":"354","author":"PM Jehle","year":"1999","unstructured":"Jehle PM, Micheler C, Jehle DR, Breitig D, Boehm BO (1999) Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens. Lancet 354:1604\u20137","journal-title":"Lancet"},{"key":"3232_CR105","doi-asserted-by":"publisher","first-page":"e8791","DOI":"10.15252\/emmm.201708791","volume":"10","author":"V Jimenez","year":"2018","unstructured":"Jimenez V, Jambrina C, Casana E, Sacristan V, Mu\u00f1oz S, Darriba S, Rod\u00f3 J, Mallol C, Garcia M, Le\u00f3n X, Marc\u00f3 S (2018) FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med 10:e8791. https:\/\/doi.org\/10.15252\/emmm.201708791","journal-title":"EMBO Mol Med"},{"key":"3232_CR106","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2014.02.004","volume":"729","author":"RB Jones","year":"2014","unstructured":"Jones RB, Vickers SP, Cheetham SC, Headland KR, Mark M, Klein T (2014) Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats. Eur J Pharmacol 729:59\u201366. https:\/\/doi.org\/10.1016\/j.ejphar.2014.02.004","journal-title":"Eur J Pharmacol"},{"issue":"L","key":"3232_CR107","first-page":"19","volume":"55","author":"SR Joshi","year":"2007","unstructured":"Joshi SR, Parikh RM, Das AK (2007) Insulin-history, biochemistry, physiology and pharmacology. J Assoc Physicians India 55(L):19","journal-title":"J Assoc Physicians India"},{"key":"3232_CR108","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","volume":"5","author":"S Kalra","year":"2014","unstructured":"Kalra S (2014) Sodium glucose co-transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology. Diabetes Ther 5:355\u2013366. https:\/\/doi.org\/10.1007\/s13300-014-0089-4","journal-title":"Diabetes Ther"},{"key":"3232_CR109","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/1932296818788349","volume":"13","author":"U Kamecke","year":"2019","unstructured":"Kamecke U, Waldenmaier D, Haug C, Ziegler R, Freckmann G (2019) Establishing methods to determine clinically relevant bolus and basal rate delivery accuracy of insulin pumps. J Diabetes Sci Technol 13:60\u201367. https:\/\/doi.org\/10.1177\/1932296818788349","journal-title":"J Diabetes Sci Technol"},{"key":"3232_CR110","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/cmi.cmi_39_17","volume":"15","author":"N Kapoor","year":"2017","unstructured":"Kapoor N, Thomas N (2017) Oral antidiabetic agents: recently available novel oral antidiabetic agents in India: a clinical review. Curr Med Issues 15:169. https:\/\/doi.org\/10.4103\/cmi.cmi_39_17","journal-title":"Curr Med Issues"},{"key":"3232_CR111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molstruc.2015.04.028","volume":"1095","author":"M Karakaya","year":"2015","unstructured":"Karakaya M, Sert Y, K\u00fcrek\u00e7i M, Eskiyurt B, \u00c7\u0131rak \u00c7 (2015) Theoretical and experimental investigations on vibrational and structural properties of tolazamide. J Mol Struct 1095:87\u201395. https:\/\/doi.org\/10.1016\/j.molstruc.2015.04.028","journal-title":"J Mol Struct"},{"issue":"Suppl","key":"3232_CR112","first-page":"41","volume":"59","author":"J Kesavadev","year":"2011","unstructured":"Kesavadev J (2011) Continuous insulin infusion systems in type 2 diabetes. J Assoc Phys India 59(Suppl):41\u201343","journal-title":"J Assoc Phys India"},{"key":"3232_CR113","doi-asserted-by":"publisher","first-page":"022","DOI":"10.14302\/issn.2574-450X.jom-19-3001","volume":"6","author":"SH Khan","year":"2019","unstructured":"Khan SH (2019) Type-2 diabetes and gene therapy-The promise of CRISPR gene therapy in type-2 diabetes mellitus. Glob J Obes Diabetes Metab Syndr 6:022\u2013024. https:\/\/doi.org\/10.14302\/issn.2574-450X.jom-19-3001","journal-title":"Glob J Obes Diabetes Metab Syndr"},{"key":"3232_CR114","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.lfs.2013.09.018","volume":"93","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Ju A, Lim SG, Kim DJ (2013) Chronic alcohol consumption, type 2 diabetes mellitus, insulin-like growth factor-I (IGF-I), and growth hormone (GH) in ethanol-treated diabetic rats. Life Sci 93:778\u201382. https:\/\/doi.org\/10.1016\/j.lfs.2013.09.018","journal-title":"Life Sci"},{"key":"3232_CR115","doi-asserted-by":"publisher","first-page":"107832","DOI":"10.1016\/j.diabres.2019.107832","volume":"156","author":"TH Kim","year":"2019","unstructured":"Kim TH, Lee K, Park IB, Choi CS, Ahn TH, Lee DH (2019) The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes. Diabetes Res Clin Pract 156:107832. https:\/\/doi.org\/10.1016\/j.diabres.2019.107832","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR116","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jflm.2019.02.013","volume":"63","author":"ML Kj\u00e6rulff","year":"2019","unstructured":"Kj\u00e6rulff ML, Astrup BS (2019) Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data. J Forensic Leg Med 63:34\u201339. https:\/\/doi.org\/10.1016\/j.jflm.2019.02.013","journal-title":"J Forensic Leg Med"},{"key":"3232_CR117","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ajcn\/80.2.257","volume":"80","author":"S Klein","year":"2004","unstructured":"Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG (2004) Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 80:257\u2013263. https:\/\/doi.org\/10.1093\/ajcn\/80.2.257","journal-title":"Am J Clin Nutr"},{"key":"3232_CR118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.diabres.2016.11.025","volume":"123","author":"BM Kocarnik","year":"2017","unstructured":"Kocarnik BM, Moore KP, Smith NL, Boyko EJ (2017) Weight change after initiation of oral hypoglycemic monotherapy for diabetes predicts 5-year mortality: an observational study. Diabetes Res Clin Pract 123:181\u201391. https:\/\/doi.org\/10.1016\/j.diabres.2016.11.025","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR119","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1331\/JAPhA.2009.08125","volume":"49","author":"L Kroon","year":"2009","unstructured":"Kroon L (2009) Overview of insulin delivery pen devices. J Am Pharm Assoc 49:e118\u2013e131. https:\/\/doi.org\/10.1331\/JAPhA.2009.08125","journal-title":"J Am Pharm Assoc"},{"key":"3232_CR222","doi-asserted-by":"publisher","unstructured":"Kumar B, Gupta SK, Saxena R, Srivastava S (2012a) Current trends in the pharmacotherapy of diabetic retinopathy. J Postgrad Med 58:132. https:\/\/doi.org\/10.4103\/0022-3859.97176","DOI":"10.4103\/0022-3859.97176"},{"key":"3232_CR223","doi-asserted-by":"publisher","unstructured":"Kumar B, Gupta SK, Nag TC, Srivastava S, Saxena R (2012b) Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Ophthalmic Res 47:103\u2013108. https:\/\/doi.org\/10.1159\/000330051","DOI":"10.1159\/000330051"},{"key":"3232_CR120","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2018.05.010","volume":"477","author":"D Kumar","year":"2018","unstructured":"Kumar D, Shankar K, Patel S, Gupta A, Varshney S, Gupta S, Rajan S, Srivastava A, Vishwakarma AL, Gaikwad AN (2018) Chronic hyperinsulinemia promotes meta-inflammation and extracellular matrix deposition in adipose tissue: implications of nitric oxide. Mol Cell Endocrinol 477:15\u201328. https:\/\/doi.org\/10.1016\/j.mce.2018.05.010","journal-title":"Mol Cell Endocrinol"},{"key":"3232_CR121","doi-asserted-by":"publisher","first-page":"S387","DOI":"10.5530\/ijper.53.3s.110","volume":"53","author":"Y Kumar","year":"2019","unstructured":"Kumar Y, Thakur AK, Goyal RK (2019) Evaluation of alpha glucosidase inhibitor (Miglitol) for its efficacy in constipation associated with diabetes. Indian J Pharm Educ 53:S387\u2013S391. https:\/\/doi.org\/10.5530\/ijper.53.3s.110","journal-title":"Indian J Pharm Educ"},{"key":"3232_CR122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cca.2019.10.043","volume":"501","author":"N Kuramoto","year":"2020","unstructured":"Kuramoto N, Koshibu M, Ishibashi M, Miyazaki A, Sumitani S, Kasayama S, Hirano T, Koga M (2020) Two cases with Hb Andrew-Minneapolis showing high or low-normal HbA1c levels depending on the measurement method. Clin Chim Acta 501:229\u2013233. https:\/\/doi.org\/10.1016\/j.cca.2019.10.043","journal-title":"Clin Chim Acta"},{"key":"3232_CR123","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.diabres.2019.04.006","volume":"151","author":"MJ Kwon","year":"2019","unstructured":"Kwon MJ, Lee YJ, Jung HS, Shin HM, Kim TN, Lee SH, Rhee BD, Kim MK, Park JH (2019) The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: a comparison with other thiazolidinediones. Diabetes Res Clin Pract 151:209\u2013223. https:\/\/doi.org\/10.1016\/j.diabres.2019.04.006","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR124","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.clnu.2018.06.930","volume":"38","author":"YJ Lai","year":"2019","unstructured":"Lai YJ, Hu HY, Lee YL, Ko MC, Ku PW, Yen YF, Chu D (2019) Frequency of alcohol consumption and risk of type 2 diabetes mellitus: a nationwide cohort study. Clin Nutr 38:1368\u20131372. https:\/\/doi.org\/10.1016\/j.clnu.2018.06.930","journal-title":"Clin Nutr"},{"key":"3232_CR125","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.15419\/bmrat.v6i1.516","volume":"6","author":"PT Le","year":"2019","unstructured":"Le PT, Phu-Van Doan N, Van Tien P, Hoang DN, Phan NK, Van Pham P (2019) A type 2 diabetes mellitus patient was successfully treated by autologous bone marrow-derived stem cell transplantation: a case report. Biomed Res Ther 6:2966\u20139. https:\/\/doi.org\/10.15419\/bmrat.v6i1.516","journal-title":"Biomed Res Ther"},{"key":"3232_CR126","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1557-0843(07)80017-0","volume":"2","author":"S Leal","year":"2007","unstructured":"Leal S, Herrier RN, Soto M (2007) The role of rapid-acting insulin analogues and inhaled insulin in type 2 diabetes mellitus. Insulin 2:61\u201367. https:\/\/doi.org\/10.1016\/S1557-0843(07)80017-0","journal-title":"Insulin"},{"key":"3232_CR127","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cnur.2017.07.012","volume":"52","author":"C Levesque","year":"2017","unstructured":"Levesque C (2017) Therapeutic lifestyle changes for diabetes mellitus. Nurs Clin 52:679\u2013692. https:\/\/doi.org\/10.1016\/j.cnur.2017.07.012","journal-title":"Nurs Clin"},{"key":"3232_CR128","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/S0140-6736(14)60613-9","volume":"383","author":"SH Ley","year":"2014","unstructured":"Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383:1999\u20132007. https:\/\/doi.org\/10.1016\/S0140-6736(14)60613-9","journal-title":"Lancet"},{"key":"3232_CR129","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2019.09.015","volume":"145","author":"XX Li","year":"2019","unstructured":"Li XX, Ling SK, Hu MY, Ma Y, Li Y, Huang PL (2019) Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4\/NLRP3 inflammasome pathway in diabetic rats. Free Radic Biol Med 145:175\u2013186. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.09.015","journal-title":"Free Radic Biol Med"},{"key":"3232_CR130","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1016\/j.vaccine.2017.10.035","volume":"35","author":"Y Li","year":"2017","unstructured":"Li Y, Cao H, Li Y, Li Z, Wei X, Jiao R, Cheng P, Liu X, Ma Y, Xing Y, Tang J (2017) Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2 (5)-P2-1 to significantly control type 1 diabetes in NOD mice. Vaccine 35:7187\u20137197. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.035","journal-title":"Vaccine"},{"key":"3232_CR131","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","volume":"16","author":"G Liu","year":"2020","unstructured":"Liu G, David BT, Trawczynski M, Fessler RG (2020) Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. Stem Cell Rev and Rep 16:3\u20132. https:\/\/doi.org\/10.1007\/s12015-019-09935-x","journal-title":"Stem Cell Rev and Rep"},{"key":"3232_CR132","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012\u2013. PMID: 31643176."},{"key":"3232_CR133","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jcjq.2018.08.006","volume":"45","author":"HW MacMaster","year":"2019","unstructured":"MacMaster HW, Gonzalez S, Maruoka A, San Luis C, Stannard D, Rushakoff JA, Rushakoff RJ (2019) Development and implementation of a subcutaneous insulin pen label bar code scanning protocol to prevent wrong-patient insulin pen errors. Jt Comm J Qual Patient Saf 45:380\u2013386. https:\/\/doi.org\/10.1016\/j.jcjq.2018.08.006","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"3232_CR134","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/diacare.9.6.637","volume":"9","author":"JI Malone","year":"1986","unstructured":"Malone JI, Lowitt S, Grove NP, Shah SC (1986) Comparison of insulin levels after injection by jet stream and disposable insulin syringe. Diabetes Care 9:637\u2013640. https:\/\/doi.org\/10.2337\/diacare.9.6.637","journal-title":"Diabetes Care"},{"key":"3232_CR224","doi-asserted-by":"publisher","unstructured":"Marques IP, Madeira MH, Messias AL, Martinho ACV, Santos T, Sousa DC, Figueira J, Cunha-Vaz J (2021) Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression. Acta Diabetol 58:197\u2013205. https:\/\/doi.org\/10.1007\/s00592-020-01602-9","DOI":"10.1007\/s00592-020-01602-9"},{"key":"3232_CR135","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ijnss.2019.09.003","volume":"6","author":"MA McCoy","year":"2019","unstructured":"McCoy MA, Theeke LA (2019) A systematic review of the relationships among psychosocial factors and coping in adults with type 2 diabetes mellitus. Int J Nurs Sci 6:468\u2013477. https:\/\/doi.org\/10.1016\/j.ijnss.2019.09.003","journal-title":"Int J Nurs Sci"},{"key":"3232_CR136","unstructured":"McCulloch DK (2009) Sulfonylureas and meglitinides in the treatment of diabetes mellitus. UpToDate, Waltham"},{"key":"3232_CR137","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/cells9020283","volume":"9","author":"B Memon","year":"2020","unstructured":"Memon B, Abdelalim EM (2020) Stem cell therapy for diabetes: beta cells versus pancreatic progenitors. Cells 9:283. https:\/\/doi.org\/10.3390\/cells9020283","journal-title":"Cells"},{"key":"3232_CR138","doi-asserted-by":"publisher","first-page":"112326","DOI":"10.1016\/j.jep.2019.112326","volume":"248","author":"Q Meng","year":"2020","unstructured":"Meng Q, Qi X, Fu Y, Chen Q, Cheng P, Yu X, Sun X, Wu J, Li W, Zhang Q, Li Y (2020) Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes. J Ethnopharmacol 248:112326. https:\/\/doi.org\/10.1016\/j.jep.2019.112326","journal-title":"J Ethnopharmacol"},{"key":"3232_CR139","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/ajcn\/71.4.921","volume":"71","author":"KA Meyer","year":"2000","unstructured":"Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR (2000) Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71:921\u2013930. https:\/\/doi.org\/10.1093\/ajcn\/71.4.921","journal-title":"Am J Clin Nutr"},{"key":"3232_CR140","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.diabet.2018.01.017","volume":"44","author":"BM Mishriky","year":"2018","unstructured":"Mishriky BM, Tanenberg RJ, Sewell KA, Cummings DM (2018) Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab 44:112\u2013120. https:\/\/doi.org\/10.1016\/j.diabet.2018.01.017","journal-title":"Diabetes Metab"},{"key":"3232_CR141","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.xphs.2019.02.021","volume":"108","author":"H Miyazaki","year":"2019","unstructured":"Miyazaki H, Atobe S, Suzuki T, Iga H, Terai K (2019) Development of pyro-drive jet injector with controllable jet pressure. J Pharm Sci 108:2415\u20132420. https:\/\/doi.org\/10.1016\/j.xphs.2019.02.021","journal-title":"J Pharm Sci"},{"key":"3232_CR142","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejcdt.2016.01.005","volume":"65","author":"HM Mohammed","year":"2016","unstructured":"Mohammed HM, Abdelkader RR, Hassan MS (2016) Insulin inhalation for diabetic patients: nursing considerations. Egypt J Chest Dis Tuberc 65:531\u2013535. https:\/\/doi.org\/10.1016\/j.ejcdt.2016.01.005","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"3232_CR143","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pcd.2014.02.004","volume":"8","author":"SM Moosheer","year":"2014","unstructured":"Moosheer SM, Waldsch\u00fctz W, Itariu BK, Brath H, Stulnig TM (2014) A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes 8:308\u2013314. https:\/\/doi.org\/10.1016\/j.pcd.2014.02.004","journal-title":"Prim Care Diabetes"},{"key":"3232_CR144","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4066\/AMJ.2014.2181","volume":"7","author":"RG Moses","year":"2014","unstructured":"Moses RG, Colagiuri S, Pollock C (2014) SGLT2 inhibitors: new medicines for addressing unmet needs in type 2 diabetes. Australas Med J 7:405\u2013415. https:\/\/doi.org\/10.4066\/AMJ.2014.2181","journal-title":"Australas Med J"},{"key":"3232_CR145","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.nurpra.2007.07.002","volume":"3","author":"BM Moyer","year":"2007","unstructured":"Moyer BM (2007) Inhaled insulin: an innovation with the potential to transform the management of Type 1 and Type 2 diabetes. J Nurse Pract 3:521\u2013527. https:\/\/doi.org\/10.1016\/j.nurpra.2007.07.002","journal-title":"J Nurse Pract"},{"key":"3232_CR146","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbrc.2013.10.059","volume":"443","author":"JS Nam","year":"2014","unstructured":"Nam JS, Kang HM, Kim J, Park S, Kim H, Ahn CW, Park JO, Kim KR (2014) Transplantation of insulin-secreting cells differentiated from human adipose tissue-derived stem cells into type 2 diabetes mice. Biochem Biophys Res Commun 443:775\u2013781. https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.059","journal-title":"Biochem Biophys Res Commun"},{"key":"3232_CR147","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bioorg.2018.02.009","volume":"77","author":"MJ Nanjan","year":"2018","unstructured":"Nanjan MJ, Mohammed M, Kumar BP, Chandrasekar MJ (2018) Thiazolidinediones as antidiabetic agents: a critical review. Bioorg Chem 77:548\u2013567. https:\/\/doi.org\/10.1016\/j.bioorg.2018.02.009","journal-title":"Bioorg Chem"},{"key":"3232_CR148","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajps.2019.04.006","volume":"15","author":"LC Ng","year":"2020","unstructured":"Ng LC, Gupta M (2020) Transdermal drug delivery systems in diabetes management: a review. Asian J Pharm Sci 15:13\u201325. https:\/\/doi.org\/10.1016\/j.ajps.2019.04.006","journal-title":"Asian J Pharm Sci"},{"key":"3232_CR149","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2755-19","author":"T Oshige","year":"2020","unstructured":"Oshige T, Nakamura Y, Sasaki Y, Kawano S, Ohki T, Tsuruta M, Tokubuchi I, Nakayama H, Yamada K, Ashida K, Tajiri Y (2020) Bromocriptine as a potential glucose-lowering agent for the treatment of prolactinoma with type 2 diabetes. Intern Med. https:\/\/doi.org\/10.2169\/internalmedicine.2755-19","journal-title":"Intern Med"},{"key":"3232_CR150","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jdiacomp.2017.11.001","volume":"32","author":"M Out","year":"2018","unstructured":"Out M, Kooy A, Lehert P, Schalkwijk CA, Stehouwer CD (2018) Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: post hoc analysis of a randomized controlled 4.3 year trial. J Diabetes Complications 32:171\u2013178. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.11.001","journal-title":"J Diabetes Complications"},{"key":"3232_CR151","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.tem.2018.03.018","volume":"29","author":"MM Page","year":"2018","unstructured":"Page MM, Johnson JD (2018) Mild suppression of hyperinsulinemia to treat obesity and insulin resistance. Trends Endrocrinol Metab 29:389\u2013399. https:\/\/doi.org\/10.1016\/j.tem.2018.03.018","journal-title":"Trends Endrocrinol Metab"},{"key":"3232_CR152","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/2042018818767220","volume":"9","author":"NM Pakkir Maideen","year":"2018","unstructured":"Pakkir Maideen NM, Manavalan G, Balasubramanian K (2018) Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter. Ther Adv Endocrinol Metab 9:259\u2013268. https:\/\/doi.org\/10.1177\/2042018818767220","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3232_CR153","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jdiacomp.2015.04.005","volume":"29","author":"A Papazafiropoulou","year":"2015","unstructured":"Papazafiropoulou A, Papanas N, Pappas S, Maltezos E, Mikhailidis DP (2015) Effects of oral hypoglycemic agents on platelet function. J Diabetes Complicat 29:846\u2013851. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.04.005","journal-title":"J Diabetes Complicat"},{"key":"3232_CR154","doi-asserted-by":"publisher","unstructured":"Patel SM, Hickman MA, Frederich R et al (2018) Assessment of adverse renal effects in patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin. https:\/\/doi.org\/10.2337\/db18-1168-P","DOI":"10.2337\/db18-1168-P"},{"key":"3232_CR155","first-page":"34","volume":"27","author":"JS Patton","year":"1997","unstructured":"Patton JS (1997) Deep-lung delivery of therapeutic proteins. ChemTech 27:34\u201338","journal-title":"ChemTech"},{"key":"3232_CR156","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/00003088-200443120-00002","volume":"43","author":"JS Patton","year":"2004","unstructured":"Patton JS, Bukar JG, Eldon MA (2004) Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin Pharmacokinet 43:781\u2013801. https:\/\/doi.org\/10.2165\/00003088-200443120-00002","journal-title":"Clin Pharmacokinet"},{"key":"3232_CR157","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.2174\/1381612823666170616081256","volume":"23","author":"S Perumalsamy","year":"2017","unstructured":"Perumalsamy S, Ain Aqilah Mohd Zin N, Teguh Widodo R, Azman Wan Ahmad W, Vethakkan RD, Zaman Huri H (2017) Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer. Curr Pharm Des 23:3689\u20133698. https:\/\/doi.org\/10.2174\/1381612823666170616081256","journal-title":"Curr Pharm Des"},{"key":"3232_CR158","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.clnu.2018.05.021","volume":"38","author":"MC Picasso","year":"2019","unstructured":"Picasso MC, Lo-Tayraco JA, Ramos-Villanueva JM, Pasupuleti V, Hernandez AV (2019) Effect of vegetarian diets on the presentation of metabolic syndrome or its components: a systematic review and meta-analysis. Clin Nutr 38:1117\u20131132. https:\/\/doi.org\/10.1016\/j.clnu.2018.05.021","journal-title":"Clin Nutr"},{"key":"3232_CR159","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/15376516.2018.1545815","volume":"29","author":"R Ponnulakshmi","year":"2019","unstructured":"Ponnulakshmi R, Shyamaladevi B, Vijayalakshmi P, Selvaraj J (2019) In silico and in vivo analysis to identify the antidiabetic activity of beta sitosterol in adipose tissue of high fat diet and sucrose induced type-2 diabetic experimental rats. Toxicol Mech Methods 29:276\u2013290. https:\/\/doi.org\/10.1080\/15376516.2018.1545815","journal-title":"Toxicol Mech Methods"},{"key":"3232_CR225","doi-asserted-by":"publisher","unstructured":"Prasathkumar M, Sadhasivam S (2021) Chitosan\/Hyaluronic acid\/Alginate and an assorted polymers loaded with honey, plant, and marine compounds for progressive wound healing\u2014Know-how. Int J Biol Macromol 186:656\u2013685. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.07.067","DOI":"10.1016\/j.ijbiomac.2021.07.067"},{"issue":"2","key":"3232_CR160","doi-asserted-by":"publisher","first-page":"18701","DOI":"10.3402\/jchimp.v2i2.18701","volume":"2","author":"CC Quianzon","year":"2012","unstructured":"Quianzon CC, Cheikh I (2012) History of insulin. J Community Hosp Intern Med Perspect 2(2):18701. https:\/\/doi.org\/10.3402\/jchimp.v2i2.18701","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"3232_CR226","doi-asserted-by":"publisher","unstructured":"Reddy S, Anoop S, Jebasingh FK, Dasgupta R, Joseph M, Saravanan B, Volena R, Mani T, Somasundaram S, Bhattacharji S, Nair SC, Paul RD, Thomas N (2021) Differentials in dietary intake of macro and micronutrients in patients with Type 2 diabetes and foot ulcers: observations from a pilot study. Clin Nutr ESPEN 47:170\u2013176. https:\/\/doi.org\/10.1016\/j.clnesp.2021.12.023","DOI":"10.1016\/j.clnesp.2021.12.023"},{"key":"3232_CR161","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.2337\/dcS13-2027","volume":"36","author":"Y Reznik","year":"2013","unstructured":"Reznik Y, Cohen O (2013) Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes. Diabetes Care 36:S219\u2013S225. https:\/\/doi.org\/10.2337\/dcS13-2027","journal-title":"Diabetes Care"},{"key":"3232_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-100596-5.21340-1","volume-title":"Role of diet on risk of diabetes","author":"D Ristic-Medic","year":"2017","unstructured":"Ristic-Medic D, Radjen S (2017) Role of diet on risk of diabetes. Elsevier, Amsterdam"},{"key":"3232_CR163","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jnim.2018.05.001","volume":"14","author":"S Rivera-Manc\u00eda","year":"2018","unstructured":"Rivera-Manc\u00eda S, Trujillo J, Chaverri JP (2018) Utility of curcumin for the treatment of diabetes mellitus: evidence from preclinical and clinical studies. J Nutr Intermed Metab 14:29\u201341. https:\/\/doi.org\/10.1016\/j.jnim.2018.05.001","journal-title":"J Nutr Intermed Metab"},{"key":"3232_CR164","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.celrep.2019.01.040","volume":"26","author":"J R\u00f6the","year":"2019","unstructured":"R\u00f6the J, Thor D, Winkler J et al (2019) Involvement of the adhesion GPCRs latrophilins in the regulation of insulin release. Cell Rep 26:1573\u20131584. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.040","journal-title":"Cell Rep"},{"key":"3232_CR165","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pcd.2019.01.009","volume":"13","author":"KP Sadarangani","year":"2019","unstructured":"Sadarangani KP, Von Oetinger A, Isla NS, Mart\u00ednez-G\u00f3mez D (2019) Leisure time physical activity is associated with better metabolic control in adults with type 1 and type 2 diabetes mellitus: a cross-sectional study from two public hospitals in Chile. Prim Care Diabetes 13:360\u2013369. https:\/\/doi.org\/10.1016\/j.pcd.2019.01.009","journal-title":"Prim Care Diabetes"},{"key":"3232_CR166","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.diabres.2018.02.026","volume":"139","author":"E Sainsbury","year":"2018","unstructured":"Sainsbury E, Kizirian NV, Partridge SR, Gill T, Colagiuri S, Gibson AA (2018) Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 139:239\u2013252. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.026","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR167","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jdiacomp.2015.12.017","volume":"30","author":"JJ Salazar","year":"2016","unstructured":"Salazar JJ, Ennis WJ, Koh TJ (2016) Diabetes medications: Impact on inflammation and wound healing. J Diabetes Complicat 30:746\u2013752. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.12.017","journal-title":"J Diabetes Complicat"},{"key":"3232_CR168","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen A, Hyttinen JM, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. J Mol Med 89:667\u2013676. https:\/\/doi.org\/10.1007\/s00109-011-0748-0","journal-title":"J Mol Med"},{"key":"3232_CR169","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lfs.2010.10.019","volume":"88","author":"Y Sato","year":"2011","unstructured":"Sato Y, Koshioka S, Kirino Y et al (2011) Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway. Life Sci 88:43\u201349. https:\/\/doi.org\/10.1016\/j.lfs.2010.10.019","journal-title":"Life Sci"},{"key":"3232_CR170","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.1996.03540160044031","volume":"276","author":"CD Saudek","year":"1996","unstructured":"Saudek CD, Duckworth WC, Giobbie-Hurder A et al (1996) Implantable insulin pump vs multiple-dose insulin for non\u2014insulin-dependent diabetes mellitus: a randomized clinical trial. JAMA 276:1322\u20131327. https:\/\/doi.org\/10.1001\/jama.1996.03540160044031","journal-title":"JAMA"},{"key":"3232_CR171","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S1262-3636(11)70972-7","volume":"37","author":"P Schaepelynck","year":"2011","unstructured":"Schaepelynck P, Darmon P, Molines L, Jannot-Lamotte MF, Treglia C, Raccah D (2011) Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. Diabetes Metab 37:S85\u2013S93. https:\/\/doi.org\/10.1016\/S1262-3636(11)70972-7","journal-title":"Diabetes Metab"},{"key":"3232_CR172","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.beem.2018.02.005","volume":"32","author":"G Sebastiani","year":"2018","unstructured":"Sebastiani G, Ceccarelli E, Castagna MG, Dotta F (2018) G-protein-coupled receptors (GPCRs) in the treatment of diabetes: current view and future perspectives. Best Pract Res Clin Endocrinol Metab 32:201\u2013213. https:\/\/doi.org\/10.1016\/j.beem.2018.02.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3232_CR173","doi-asserted-by":"publisher","first-page":"152901","DOI":"10.1016\/j.phymed.2019.152901","volume":"59","author":"V Sekar","year":"2019","unstructured":"Sekar V, Mani S, Malarvizhi R, Nithya P, Vasanthi HR (2019) Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide. Phytomedicine 59:152901. https:\/\/doi.org\/10.1016\/j.phymed.2019.152901","journal-title":"Phytomedicine"},{"key":"3232_CR174","doi-asserted-by":"publisher","first-page":"553","DOI":"10.12809\/hkmj154557","volume":"21","author":"S Shahani","year":"2015","unstructured":"Shahani S, Shahani L (2015) Use of insulin in diabetes: a century of treatment. Hong Kong Med J 21:553\u2013559. https:\/\/doi.org\/10.12809\/hkmj154557","journal-title":"Hong Kong Med J"},{"key":"3232_CR175","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cegh.2013.03.002","volume":"2","author":"P Sharma","year":"2014","unstructured":"Sharma P, Visnegarwala F, Tripathi V (2014) Burgeoning double burden of tuberculosis and diabetes in India: magnitude of the problem\u2013Strategies and solutions. Clin Epidemiol Glob Health 2:107\u2013116. https:\/\/doi.org\/10.1016\/j.cegh.2013.03.002","journal-title":"Clin Epidemiol Glob Health"},{"key":"3232_CR227","doi-asserted-by":"publisher","unstructured":"Sharma Y, Saxena S, Mishra A, Saxena A, Natu SM (2017) Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss. Eur J Nutr 56:2013\u20132027. https:\/\/doi.org\/10.1007\/s00394-017-1406-2","DOI":"10.1007\/s00394-017-1406-2"},{"key":"3232_CR176","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2251-6581-12-14","volume":"12","author":"SR Shrivastava","year":"2013","unstructured":"Shrivastava SR, Shrivastava PS, Ramasamy J (2013) Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord 12:14. https:\/\/doi.org\/10.1186\/2251-6581-12-14","journal-title":"J Diabetes Metab Disord"},{"key":"3232_CR177","doi-asserted-by":"publisher","first-page":"100186","DOI":"10.1016\/j.obmed.2020.100186","volume":"17","author":"NT Shurrab","year":"2020","unstructured":"Shurrab NT, Arafa ESA (2020) Metformin: a review of its therapeutic efficacy and adverse effects. Obes Med 17:100186. https:\/\/doi.org\/10.1016\/j.obmed.2020.100186","journal-title":"Obes Med"},{"key":"3232_CR178","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcjd.2012.11.001","volume":"37","author":"JL Sievenpiper","year":"2013","unstructured":"Sievenpiper JL, Dworatzek PD (2013) Food and dietary pattern-based recommendations: an emerging approach to clinical practice guidelines for nutrition therapy in diabetes. Can J Diabetes 37:51\u201357. https:\/\/doi.org\/10.1016\/j.jcjd.2012.11.001","journal-title":"Can J Diabetes"},{"key":"3232_CR179","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/antiox9010040","volume":"9","author":"SP Singh","year":"2020","unstructured":"Singh SP, Greenberg M, Glick Y et al (2020) Adipocyte specific HO-1 gene therapy is effective in antioxidant treatment of insulin resistance and vascular function in an obese mice model. Antioxidants 9:40. https:\/\/doi.org\/10.3390\/antiox9010040","journal-title":"Antioxidants"},{"key":"3232_CR180","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/193229680800200624","volume":"2","author":"MJ Skladany","year":"2008","unstructured":"Skladany MJ, Miller M, Guthermann JS, Ludwig CR (2008) Patch-pump technology to manage type 2 diabetes mellitus: hurdles to market acceptance. J Diabetes Sci Technol 2:1147\u20131150. https:\/\/doi.org\/10.1177\/193229680800200624","journal-title":"J Diabetes Sci Technol"},{"key":"3232_CR181","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13098-019-0415-0","volume":"11","author":"MA Solis","year":"2019","unstructured":"Solis MA, Vel\u00e1squez IM, Correa R, Huang LL (2019) Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America. Diabetol Metab Syndr 11:20. https:\/\/doi.org\/10.1186\/s13098-019-0415-0","journal-title":"Diabetol Metab Syndr"},{"key":"3232_CR182","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","volume":"358","author":"ND Sora","year":"2019","unstructured":"Sora ND, Shashpal F, Bond EA, Jenkins AJ (2019) Insulin pumps: review of technological advancement in diabetes management. Am J Med Sci 358:326\u2013331. https:\/\/doi.org\/10.1016\/j.amjms.2019.08.008","journal-title":"Am J Med Sci"},{"key":"3232_CR183","doi-asserted-by":"publisher","first-page":"103290","DOI":"10.1016\/j.bioorg.2019.103290","volume":"92","author":"FM Sroor","year":"2019","unstructured":"Sroor FM, Abbas SY, Basyouni WM et al (2019) Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents. Bioorg Chem 92:103290. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103290","journal-title":"Bioorg Chem"},{"key":"3232_CR184","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bone.2018.04.004","volume":"112","author":"TB Stage","year":"2018","unstructured":"Stage TB, Christensen MMH, J\u00f8rgensen NR, Beck-Nielsen H, Br\u00f8sen K, Gram J, Frost M (2018) Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes. Bone 112:35\u201341. https:\/\/doi.org\/10.1016\/j.bone.2018.04.004","journal-title":"Bone"},{"key":"3232_CR185","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/14740338.2013.752813","volume":"12","author":"SA Stein","year":"2013","unstructured":"Stein SA, Lamos EM, Davis SN (2013) A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf 12:153\u2013175. https:\/\/doi.org\/10.1517\/14740338.2013.752813","journal-title":"Expert Opin Drug Saf"},{"key":"3232_CR186","doi-asserted-by":"publisher","first-page":"e99114","DOI":"10.1172\/jci.insight.99114","volume":"3","author":"P Steneberg","year":"2018","unstructured":"Steneberg P, Lindahl E, Dahl U et al (2018) PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients. JCI Insight 3:e99114. https:\/\/doi.org\/10.1172\/jci.insight.99114","journal-title":"JCI Insight"},{"key":"3232_CR187","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","volume":"378","author":"AA Tahrani","year":"2011","unstructured":"Tahrani AA, Bailey CJ, Del Prato S, Barnett AH (2011) Management of type 2 diabetes: new and future developments in treatment. The Lancet 378:182\u2013197. https:\/\/doi.org\/10.1016\/S0140-6736(11)60207-9","journal-title":"The Lancet"},{"key":"3232_CR188","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","volume":"13","author":"SY Tan","year":"2019","unstructured":"Tan SY, Wong JLM, Sim YJ et al (2019) Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr 13:364\u2013372. https:\/\/doi.org\/10.1016\/j.dsx.2018.10.008","journal-title":"Diabetes Metab Syndr"},{"key":"3232_CR189","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/S0735-1097(01)01655-2","volume":"38","author":"M Tanasescu","year":"2001","unstructured":"Tanasescu M, Hu FB, Willett WC, Stampfer MJ, Rimm EB (2001) Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol 38:1836\u20131842","journal-title":"J Am Coll Cardiol"},{"key":"3232_CR190","doi-asserted-by":"publisher","first-page":"e1352","DOI":"10.1016\/S2214-109X(18)30387-5","volume":"6","author":"N Tandon","year":"2018","unstructured":"Tandon N, Anjana RM, Mohan V et al (2018) The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990\u20132016. Lancet Glob Health 6:e1352\u2013e1362. https:\/\/doi.org\/10.1016\/S2214-109X(18)30387-5","journal-title":"Lancet Glob Health"},{"key":"3232_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109410","volume":"119","author":"G Tang","year":"2019","unstructured":"Tang G, Duan F, Li W et al (2019) Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in ApoE\u2212\/\u2212 mice. Biomed Pharmacother 119:109410. https:\/\/doi.org\/10.1016\/j.biopha.2019.109410","journal-title":"Biomed Pharmacother"},{"key":"3232_CR192","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jchromb.2018.09.001","volume":"1097","author":"P Tao","year":"2018","unstructured":"Tao P, Li Z, Matsuda R, Hage DS (2018) Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns. J Chromatogr B 1097:64\u201373. https:\/\/doi.org\/10.1016\/j.jchromb.2018.09.001","journal-title":"J Chromatogr B"},{"key":"3232_CR193","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.procs.2019.11.084","volume":"160","author":"M Ubl","year":"2019","unstructured":"Ubl M, Koutny T (2019) SmartCGMS as an environment for an insulin-pump development with FDA-accepted in-silico pre-clinical trials. Procedia Comput Sci 160:322\u2013329. https:\/\/doi.org\/10.1016\/j.procs.2019.11.084","journal-title":"Procedia Comput Sci"},{"key":"3232_CR194","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2017.08.010","volume":"78","author":"J Upadhyay","year":"2018","unstructured":"Upadhyay J, Polyzos SA, Perakakis N et al (2018) Pharmacotherapy of type 2 diabetes: an update. Metabolism 78:13\u201342. https:\/\/doi.org\/10.1016\/j.metabol.2017.08.010","journal-title":"Metabolism"},{"key":"3232_CR195","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.diabres.2016.12.002","volume":"126","author":"K Van Brunt","year":"2017","unstructured":"Van Brunt K, Pedersini R, Rooney J, Corrigan SM (2017) Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: a cross-sectional survey study. Diabetes Res Clin Pract 126:30\u201342. https:\/\/doi.org\/10.1016\/j.diabres.2016.12.002","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR196","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4239\/wjd.v3.i8.142","volume":"3","author":"PR van Dijk","year":"2012","unstructured":"van Dijk PR, Logtenberg SJ, Groenier KH, Haveman JW, Kleefstra N, Bilo HJ (2012) Complications of continuous intraperitoneal insulin infusion with an implantable pump. World J Diabetes 3:142. https:\/\/doi.org\/10.4239\/wjd.v3.i8.142","journal-title":"World J Diabetes"},{"key":"3232_CR197","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/524039a","volume":"524","author":"O Veiseh","year":"2015","unstructured":"Veiseh O, Langer R (2015) A smart insulin patch. Nature 524:39\u201341. https:\/\/doi.org\/10.1038\/524039a","journal-title":"Nature"},{"key":"3232_CR198","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI16567","volume":"111","author":"B Viollet","year":"2003","unstructured":"Viollet B, Andreelli F, J\u00f8rgensen SB et al (2003) The AMP-activated protein kinase \u03b12 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111:91\u201398. https:\/\/doi.org\/10.1172\/JCI16567","journal-title":"J Clin Invest"},{"key":"3232_CR199","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00394-015-0983-1","volume":"55","author":"M Vitale","year":"2016","unstructured":"Vitale M, Masulli M, Rivellese AA et al (2016) Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes\u2014The TOSCA. IT Study Eur J Nutr 55:1645\u20131651. https:\/\/doi.org\/10.1007\/s00394-015-0983-1","journal-title":"IT Study Eur J Nutr"},{"key":"3232_CR200","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1464-5491.2005.01597.x","volume":"22","author":"J Wainstein","year":"2005","unstructured":"Wainstein J, Metzger M, Boaz M et al (2005) Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 22:1037\u20131046. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01597.x","journal-title":"Diabet Med"},{"key":"3232_CR201","doi-asserted-by":"publisher","first-page":"110965","DOI":"10.1016\/j.fct.2019.110965","volume":"135","author":"J Wang","year":"2020","unstructured":"Wang J, He Y, Yu D, Jin L, Gong X, Zhang B (2020) Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K\/AKT signaling pathway in type-2 diabetic KKAy mice. Food Chem Toxicol 135:110965. https:\/\/doi.org\/10.1016\/j.fct.2019.110965","journal-title":"Food Chem Toxicol"},{"key":"3232_CR202","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.bcp.2013.10.005","volume":"86","author":"X Wang","year":"2013","unstructured":"Wang X, Zhang DM, Gu TT et al (2013) Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1\/sphingosine 1-phosphate signaling pathway. Biochem Pharmacol 86:1791\u20131804. https:\/\/doi.org\/10.1016\/j.bcp.2013.10.005","journal-title":"Biochem Pharmacol"},{"key":"3232_CR203","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3389\/fphar.2018.01491","volume":"9","author":"YM Wang","year":"2019","unstructured":"Wang YM, Liu HX, Fang NY (2019) High Glucose concentration impairs 5-PAHSA activity by inhibiting AMP-activated protein kinase activation and promoting nuclear factor-kappa-B-mediated inflammation. Front Pharmacol 9:1491. https:\/\/doi.org\/10.3389\/fphar.2018.01491","journal-title":"Front Pharmacol"},{"key":"3232_CR204","doi-asserted-by":"publisher","first-page":"87","DOI":"10.21037\/sci.2016.11.14","volume":"3","author":"T Wehbe","year":"2016","unstructured":"Wehbe T, Abi Chahine N, Sissi S, Abou-Joaude I, Chalhoub L (2016) Bone marrow derived stem cell therapy for type 2 diabetes mellitus. Stem Cell Invest 3:87. https:\/\/doi.org\/10.21037\/sci.2016.11.14","journal-title":"Stem Cell Invest"},{"key":"3232_CR205","first-page":"718","volume":"87","author":"CM Weiland","year":"2013","unstructured":"Weiland CM, Hilaire ML (2013) Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus. Am Fam Phys 87:718\u2013720","journal-title":"Am Fam Phys"},{"key":"3232_CR228","doi-asserted-by":"publisher","unstructured":"Wong MY, Man RE, Fenwick EK, Gupta P, Li LJ, van Dam RM, Chong MF, Lamoureux EL (2018) Dietary intake and diabetic retinopathy: a systematic review. PLoS One 13:e0186582. https:\/\/doi.org\/10.1371\/journal.pone.0186582","DOI":"10.1371\/journal.pone.0186582"},{"key":"3232_CR206","doi-asserted-by":"publisher","first-page":"78086","DOI":"10.18632\/oncotarget.17475","volume":"8","author":"PC Wu","year":"2017","unstructured":"Wu PC, Wu VC, Lin CJ et al (2017) Meglitinides increase the risk of hypoglycemia in diabetic patients with advanced chronic kidney disease: a nationwide, population-based study. Oncotarget 8:78086. https:\/\/doi.org\/10.18632\/oncotarget.17475","journal-title":"Oncotarget"},{"key":"3232_CR229","doi-asserted-by":"publisher","unstructured":"Yazdanpanah L, Nasiri M, Adarvishi S (2015) Literature review on the management of diabetic foot ulcer. World J Diabetes 6:37. https:\/\/doi.org\/10.4239\/wjd.v6.i1.37","DOI":"10.4239\/wjd.v6.i1.37"},{"key":"3232_CR207","first-page":"1717","volume":"2","author":"KA Yogendraji","year":"2011","unstructured":"Yogendraji KA, Lokwani P, Singh N (2011) Newer strategies for insulin delivery. Int J Res Ayurveda Pharm 2:1717\u20131721","journal-title":"Int J Res Ayurveda Pharm"},{"key":"3232_CR208","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.clnu.2019.08.008","volume":"39","author":"Z Yu","year":"2020","unstructured":"Yu Z, Nan F, Wang LY, Jiang H, Chen W, Jiang Y (2020) Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 39:1724\u20131734. https:\/\/doi.org\/10.1016\/j.clnu.2019.08.008","journal-title":"Clin Nutr"},{"key":"3232_CR209","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.stem.2017.06.016","volume":"21","author":"J Yue","year":"2017","unstructured":"Yue J, Gou X, Li Y, Wicksteed B, Wu X (2017) Engineered epidermal progenitor cells can correct diet-induced obesity and diabetes. Cell Stem Cell 21:256\u2013263. https:\/\/doi.org\/10.1016\/j.stem.2017.06.016","journal-title":"Cell Stem Cell"},{"key":"3232_CR210","doi-asserted-by":"publisher","unstructured":"Zabaleta-del-Olmo E, Vlacho B, Jodar-Fern\u00e1ndez L et al (2016) Safety of the reuse of needles for subcutaneous insulin injection: a systematic review and meta-analysis.\u00a0Int\u200b J Nurs Stud\u00a060:121\u2013132. https:\/\/doi.org\/10.1016\/j.ijnurstu.2016.04.010","DOI":"10.1016\/j.ijnurstu.2016.04.010"},{"key":"3232_CR211","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.2337\/db11-1373","volume":"61","author":"W Zhang","year":"2012","unstructured":"Zhang W, Zhang X, Wang H et al (2012) AMP-activated protein kinase \u03b11 protects against diet-induced insulin resistance and obesity. Diabetes 61:3114\u20133125. https:\/\/doi.org\/10.2337\/db11-1373","journal-title":"Diabetes"},{"key":"3232_CR212","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14336\/AD.2019.0421","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen W, Feng B, Cao H (2020a) The clinical efficacy and safety of stem cell therapy for diabetes Mellitus: a systematic review and meta-analysis. Aging Dis 11:141. https:\/\/doi.org\/10.14336\/AD.2019.0421","journal-title":"Aging Dis"},{"key":"3232_CR213","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.addr.2018.12.006","volume":"139","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z (2019) Advances in transdermal insulin delivery. Adv Drug Deliv Rev 139:51\u201370. https:\/\/doi.org\/10.1016\/j.addr.2018.12.006","journal-title":"Adv Drug Deliv Rev"},{"key":"3232_CR214","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.diabres.2019.107990","volume":"159","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Cao Y, Tao Y, Meng E, Tang J, Liu Y, Li F (2020b) Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pract 159:107990. https:\/\/doi.org\/10.1016\/j.diabres.2019.107990","journal-title":"Diabetes Res Clin Pract"},{"key":"3232_CR215","doi-asserted-by":"publisher","first-page":"e3243","DOI":"10.1002\/dmrr.3243","volume":"36","author":"B Zhao","year":"2020","unstructured":"Zhao B, Deng H, Li B et al (2020) Association of magnesium consumption with type 2 diabetes and glucose metabolism: A systematic review and pooled study with trial sequential analysis. Diabetes Metab Res Rev 36:e3243. https:\/\/doi.org\/10.1002\/dmrr.3243","journal-title":"Diabetes Metab Res Rev"},{"key":"3232_CR216","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tvjl.2016.12.006","volume":"219","author":"E Zini","year":"2017","unstructured":"Zini E, Padrutt I, Macha K, Riederer A, Pesaresi M, Lutz TA, Reusch CE (2017) Use of an implantable pump for controlled subcutaneous insulin delivery in healthy cats. Vet J 219:60\u201364. https:\/\/doi.org\/10.1016\/j.tvjl.2016.12.006","journal-title":"Vet J"},{"key":"3232_CR217","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s13300-010-0004-6","volume":"1","author":"HC Zisser","year":"2010","unstructured":"Zisser HC (2010) The OmniPod Insulin Management System: the latest innovation in insulin pump therapy. Diabetes Ther 1:10\u201324. https:\/\/doi.org\/10.1007\/s13300-010-0004-6","journal-title":"Diabetes Ther"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-022-03232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-022-03232-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-022-03232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T12:26:56Z","timestamp":1647433616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-022-03232-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":227,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3232"],"URL":"https:\/\/doi.org\/10.1007\/s10529-022-03232-3","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"6 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}